ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025
Effect of Glucose Metabolic State Transition on Progression from Stage A to Stage C Heart Failure.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heart failure (HF) constitutes a significant global health challenge. The interplay between the dynamics of glucose metabolic status transitions and the progression of HF has been minimally explored. Objective: We assessed the impact of shifts in glucose metabolic states on the progression from stage A to stage C HF. Methods: The Kailuan Study is a large-scale prospective cohort study. Based on data from the Kailuan Study, 41,110 stage A HF patients were included and stratified into 6 groups based on alterations in glucose metabolic status: stable normoglycemic, stable pre-diabetes, diabetes, normoglycemic progressing to pre-diabetes, pre-diabetes back to normoglycemic, and normoglycemic/pre-diabetes progressing to diabetes. Utilizing the Cox proportional hazards regression model, we calculated the hazard ratios (HR) and 95% confidence intervals (CI) associated with the transition to stage C HF among patients with stage A HF with different glucose metabolic state transitions. Results: Our findings indicated a notably elevated risk for the progression to stage C HF within the diabetic group relative to the stable normoglycemic group (HR, 1.87; 95% CI, 1.66 to 2.10). Additionally, an augmented risk for the progression to stage C HF was observed in the normoglycemic/pre-diabetic to diabetic group (HR, 1.38; 95% CI, 1.15 to 1.65). Conclusion: Both diabetes and normoglycemic/pre-diabetes progressing to diabetes are associated with heightened risks of progressing from stage A to stage C HF. Conversely, the re-establishment of normoglycemic in pre-diabetes is associated with preventing HF progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.